Log in
Enquire now
‌

US Patent 8999325 Treatment of ocular disease

Patent 8999325 was granted and assigned to Aerpio Therapeutics on April, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
Current Assignee
Aerpio Therapeutics
Aerpio Therapeutics
Date Filed
October 15, 2012
Date of Patent
April 7, 2015
Patent Applicant
Aerpio Therapeutics
Aerpio Therapeutics
Patent Application Number
13652154
Patent Citations Received
‌
US Patent 12064420 Tie-2 activators targeting the Schlemm's canal
0
‌
US Patent 11666558 Methods of treating intraocular pressure with activators of Tie-2
0
‌
US Patent 11873334 Method of treating ocular conditions by administering an antibody that activates Tie2 and binds VEGF
0
Patent Inventor Names
Kevin Peters
0
Robert Shalwitz
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
8999325
Patent Primary Examiner
‌
Phuong Huynh

Find more entities like US Patent 8999325 Treatment of ocular disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.